Skip to main content
Clinical Trials/ACTRN12607000301460
ACTRN12607000301460
Completed
Phase 3

A randomised clinical trial to compare the efficacy of nebulized N-acetylcysteine and normal saline in improving sputum quality and diagnostic yield in patients with chest infections.

Austin Health0 sites190 target enrollmentJune 5, 2007

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Sputum quality, chest infections
Sponsor
Austin Health
Enrollment
190
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 5, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Differential diagnosis inclusive of lower respiratory tract infection as determined by the treating physician (eg. cough, fever, pleuritic chest pain, dyspnoea, decreased breath sounds, bronchial breath sounds, crackles on auscultation) ·A sputum sample is to be collected in the ED.

Exclusion Criteria

  • Inability to co\-operate or consent due to debility, significant illness, language barriers, altered consciousness (as determined by the ED or study staff)·Refusal to participate·Pregnancy or breast\-feeding·Known allergy to NAC·Presence of significant hepatic or renal failure·Presence of other significant co\-morbidities eg. HIV, immunocompromised, cystic fibrosis, bronchiectasis·CXR suggestive of TB·Recent hospital admission within the previous 14 days inclusively·Current treatment with \>10mg prenisolone daily for more than 1 month inclusively

Outcomes

Primary Outcomes

Not specified

Similar Trials